from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2168c/-

LFCtreatmentdescriptionclass of inhibitor

-0.119

Amikacinug/mL Amikacintranslation

0.751

Cap5-10ug/mL Capreomycintranslation

0.154

Rox10-50 ug/mL Roxithromycintranslation

-0.285

SM2-5 ug/mL Streptomycintranslation

0.390

Tet5-10 ug/mL Tetracyclinetranslation

-0.067

Rif0.2-5ug/mL Rifampicintranscription

-0.826

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.339

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.351

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.710

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.075

Clofazimine10-13 ug/mL Clofaziminerespiration

0.283

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.818

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.213

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.929

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.581

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.281

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.357

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.450

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.208

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.060

KCN5-20 ug/mL Potassium cyaniderespiration

2.047

NaN30.2-2 mM Sodium aziderespiration

0.695

Nigericin50 uM Nigericinrespiration

0.295

TRC10-150 ug/mL Triclosanrespiration

-1.436

TRZ10-25 ug/mL Thioridazinerespiration

1.993

Valinomycin0.5-10 uM Valinomycinrespiration

0.159

ZnSO42 mM ZnSO4respiration

-0.050

menadione6-10 ug/mL Menadionerespiration

-0.345

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.107

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.769

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.352

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.984

NRP_1Non-replicating persistence stage 1dosRassociated

-0.203

Amp0.2mg/mL AmpicillincellWall

-0.022

Cephalexin20-100 ug/mL CephalexincellWall

-0.030

Cerulenin0.32-5 ug/mL CerulenincellWall

0.717

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.107

EMB10-20 ug/mL EthambutolcellWall

-0.162

Eta12-40 ug/mL EthionamidecellWall

-0.095

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.353

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.305

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.005

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.789

BZA0.12 mg/mL BenzamidearomaticAmides

0.683

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.777

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.027

H2O24 mM hydrogen peroxideDNAdamaging

-0.150

Levo10 ug/mL LevofloxacinDNAdamaging

0.324

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.899

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.352

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.187

UVUV-irradiationDNAdamaging

-1.908

ARP41-4 ug/mL Antitubercular compound ARP4?

0.337

Antimycin12.5-50 ug/mL Antimycin A?

0.121

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.291

PA_110-50 ug/mL Antitubercular compound PA-1?

0.923

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.208

PA8240.2-2 ug/mL PA-824?

0.095

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.234

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.454

Verapamil50 uM Verapamil?

0.619

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.148

methoxatin10-20 ug/mL Methoxatin?